Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1COVID-19 1

Interventions

Exercise 16Standard of Care 10Control Groups 9Surgical Procedures, Operative 8Radiotherapy, Intensity-Modulated 6Radiotherapy 6Endoscopic Mucosal Resection 6Drug Therapy 6Blood Specimen Collection 6Indocyanine Green 5apatinib 4anlotinib 4Metformin 4Magnetic Resonance Spectroscopy 4Laparoscopy 4Fluorouracil 4Cisplatin 4camrelizumab 3Vitamin D 3Ultrasonography 3Therapeutics 3Sentinel Lymph Node Biopsy 3Saline Solution 3Radiofrequency Ablation 3Quality of Life 3Proton Therapy 3Preoperative Exercise 3Methylene Blue 3Mammography 3Magnetic Resonance Imaging 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × sinovac COVID-19 vaccine × Clear all
NCT05313074 2022-04-15

SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients

National Cancer Institute, Thailand

Phase NA Completed
311 enrolled

COVID-19, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡